Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Vicore Pharma Holding AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 363 More Arrow 450 More Arrow 2,499
Earnings before taxes -315,383 More Arrow -273,185 Less Arrow -289,383
EBITDA -322,296 More Arrow -271,825 Less Arrow -284,004
Total assets 504,326 Less Arrow 319,725 More Arrow 439,989
Current assets 502,053 Less Arrow 255,198 More Arrow 368,567
Current liabilities 39,286 More Arrow 43,788 More Arrow 63,945
Equity capital 461,324 Less Arrow 273,447 More Arrow 373,818
- share capital 56,589 Less Arrow 38,711 Less Arrow 34,991
Employees (average) 25 Less Arrow 21 Less Arrow 16

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 91.5% Less Arrow 85.5% Less Arrow 85.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -62.5% Less Arrow -85.3% More Arrow -65.2%
Current ratio 1277.9% Less Arrow 582.8% Less Arrow 576.4%
Return on equity (ROE) -68.4% Less Arrow -99.9% More Arrow -77.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 More Arrow 5 Less Arrow 3
Chg. No. of employees % 19% More Arrow 31% Less Arrow 23%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.